Baxter SA
901.3 FTEThe score of Baxter shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +4 % Equity +25 % Total assets +13 % Headcount (avg FTE) -2 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Baxter's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Baxter's financial analysis
- Solvency52.4%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Baxter
Baxter's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.093.693
- VAT number
- BE0403093693
- Peppol
- Registered · 0208:0403093693 · as of 01 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jan 1968
- Registered office
- 7860 Lessines
- Size
- Large · 901.3 FTE
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Baxter (SA) has been based in Lessines since 1968, active in: manufacture of medicaments. For 2025, it reports revenue of €106.6m, a net profit of €6.15m and equity of €83.8m. With 901.3 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 52.4%, above the median of its sector (34.4%).
Companies similar to Baxter
Companies in the same business, of comparable size and area, outside its group.
- Odyssea Pharma Manufacture of pharmaceutical preparations Grâce-Hollogne · balance sheet €91.0m
- Novo Nordisk Production Belgium SA Manufacture of pharmaceutical preparations Brussels · balance sheet €153.5m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- KELA - Kempisch Laboratorium - Kela Laboratoria Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €63.2m
- Novartis Manufacturing Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €285.2m
- Ipsen Manufacture of pharmaceutical preparations Brussels · balance sheet €134.4m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- Baxalta Belgium Manufacturing Manufacture of basic pharmaceutical products Lessines · balance sheet €713.1m
Frequently asked questions about Baxter
What is the revenue of Baxter?
According to the 2025 annual accounts filed with the NBB, the revenue of Baxter amounts to 106,551,488 €.
What is the VAT number of Baxter?
In Belgium, the VAT number is the company number prefixed with BE: BE0403093693 for Baxter, if the company is VAT-registered. Its company number (CBE) is 0403.093.693.
Where is the registered office of Baxter?
According to the CBE register, the registered office of Baxter is in 7860 Lessines.
What is the equity of Baxter?
At the close of the 2025 financial year, the equity of Baxter amounts to 83,811,817 €, a solvency of 52.4% of total assets.
How many people work at Baxter?
901.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Baxter?
The register lists 6 active mandates at Baxter. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Baxter
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →